跳至主要内容
临床试验/ACTRN12613001084774
ACTRN12613001084774已完成4 期

An acute, double blind, placebo-controlled crossover study of 320mg, 640mg and 960mg doses of a special extract of Bacopa Monnieri (CDRI08) on sustained cognitive performance and mood in healthy adults

Swinburne University of Technology0 个研究点目标入组 35 人开始时间: 2013年9月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Non-smoker
  • - Age between 18 and 55 years
  • - Healthy (absence of all exclusion criteria) male and female adults
  • - Not taking any medication, herbal extracts, or illicit drugs
  • - Not pregnant or lactating
  • - Participants must abstain from caffeine-containing foods/beverages and alcohol for 24 hours prior to the training session and each testing session.
  • - Written informed consent obtained

排除标准

  • - Heavy regular use of alcohol (more than 14 standard drinks per week)
  • - Existing or pre-existing physical or neurological conditions
  • - History of psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders
  • - Existing chronic illness and infection
  • - Taking any medication, herbal extracts, dietary supplements (which may influence cognitive or mood) or illicit drugs
  • - Pregnant or lactating

研究者

相似试验